On June 16, Senate Finance Committee Democrats released an RFI on proposals to lower the cost of prescription drugs. On Aug. 17, AMCP submitted comments in response.
AMCP Comment Letter on Health Technology Ecosystem
As CMS explores strategies to increase the adoption of digital health tools, AMCP urges CMS to support broader coverage of prescription digital therapeutics (PDTs) under Medicare and Medicaid. PDTs represent an emerging class of software-based treatments that deliver clinically validated therapeutic benefits, either independently or in combination with other interventions. These products can play a transformative role in improving access, especially for patients with behavioral health conditions or chronic diseases.
Related
On June 5, the New York State Assembly passed S.5939C/A.5882C, commonly referred to as the Patient Access to Pharmacy Act (PAPA), sending the pharmacy benefit manager (PBM) reimbursement legislation to Governor Kathy Hochul for consideration. The Senate previously passed the measure on May 28.
Featured News & Resources
See Full Calendar
Other Events
AMCP Florida-Puerto Rico Day of Education 2026
Other Events
AMCP Georgia Day of Education 2026
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
